Literature DB >> 6732473

Resection of hepatic metastases from colorectal cancer.

M A Adson, J A van Heerden, M H Adson, J S Wagner, D M Ilstrup.   

Abstract

We studied 141 patients who had resection of hepatic metastases from colorectal cancer, considering all such lesions removed between 1948 and 1982. The study involved extended observations of patients described previously. Also included were 21 patients who had wedge resections of small metastases done since 1976, who, therefore, did not qualify for analysis of major hepatic resections reported recently (1980 and 1983). The overall five-year survival rate was 25%, significantly higher than that of a group of historical controls who had resectable metastases that were not removed. The size and nature of our extended sample allowed identification of some determinants of favorable prognosis: Dukes' stage of the primary lesion, absence of extrahepatic metastases, and being female. Contrary to our earlier observations, this study justified removal of some multiple hepatic metastases.

Entities:  

Mesh:

Year:  1984        PMID: 6732473     DOI: 10.1001/archsurg.1984.01390180015003

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  108 in total

Review 1.  Current treatment for colorectal liver metastases.

Authors:  Evangelos P Misiakos; Nikolaos P Karidis; Gregory Kouraklis
Journal:  World J Gastroenterol       Date:  2011-09-28       Impact factor: 5.742

Review 2.  The changing face of hepatic resection.

Authors:  S Iwatsuki; D G Sheahan; T E Starzl
Journal:  Curr Probl Surg       Date:  1989-05       Impact factor: 1.909

3.  Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors.

Authors:  K S Hughes; R B Rosenstein; S Songhorabodi; M A Adson; D M Ilstrup; J G Fortner; B J Maclean; J H Foster; J M Daly; D Fitzherbert
Journal:  Dis Colon Rectum       Date:  1988-01       Impact factor: 4.585

4.  Hepatic artery chemotherapy in the management of colorectal metastases.

Authors:  Stacy L Stratmann
Journal:  Proc (Bayl Univ Med Cent)       Date:  2002-10

Review 5.  Current directions in chemotherapy for colorectal cancer.

Authors:  Yasuhiro Inoue; Chikao Miki; Masato Kusunoki
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

Review 6.  Resection of colorectal liver metastases revisited.

Authors:  J Scheele; C Rudroff; A Altendorf-Hofmann
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

7.  Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases?

Authors:  Nir Lubezky; Ravit Geva; Einat Shmueli; Richard Nakache; Joseph M Klausner; Arie Figer; Menahem Ben-Haim
Journal:  World J Surg       Date:  2009-05       Impact factor: 3.352

8.  Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients.

Authors:  Timothy M Pawlik; Francesco Izzo; Deborah S Cohen; Jeffery S Morris; Steven A Curley
Journal:  Ann Surg Oncol       Date:  2003-11       Impact factor: 5.344

9.  Liver resection for metastatic colorectal cancer.

Authors:  S Iwatsuki; C O Esquivel; R D Gordon; T E Starzl
Journal:  Surgery       Date:  1986-10       Impact factor: 3.982

10.  Procedures of choice for resection of primary and recurrent liver metastases from colorectal cancer.

Authors:  Kuniya Tanaka; Hiroshi Shimada; Mitsuyoshi Ohta; Shinji Togo; Shuji Saitou; Shigeki Yamaguchi; Itaru Endo; Hitoshi Sekido
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.